ArticlePDF Available

EVALUATION OF HICROME AGAR – CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS

Authors:
  • ESIC MEDICAL COLLEGE GULBARGA

Abstract and Figures

Background of study: Oral candidiasis is the most common opportunistic infection in HIV seropositive patients, also predictive of immunosuppression. Though Candida albicans is the predominant isolate in oral candidiasis, there is rise in non albicans Candida infection coupled with high levels of antifungal resistance. There is urgent need for rapid, simple and reliable method to identify yeast isolates. Hicrome agar-Candida is a selective and differential medium for identification of yeasts directly from clinical samples. This medium allows selective isolation of yeasts and simultaneously identifies certain species of Candida. Aim / Objective: To evaluate the utility of Hicrome agar-Candida in identification of C. albicans and non albicans Candida. Research Methodology: Two oral swabs obtained from 100 HIV seropositive patients having oral candidiasis were subjected to identification and characterization by standard conventional methods. Simultaneously direct inoculation was done on Hicrome agar-Candida plate. Conclusion: Of the total 100 samples 103 species were obtained. C. tropicalis was the most common species isolated followed by C. guilliermondi, C. parapsilosis, C. kefyr, C. albicans, C. krusei, C. glabrata, C. fomata and C. pelliculosa. Hicrome agar showed selective growth of all Candida species with distinguishing color for each species. C. tropicalis showed blue color with sensitivity (68%) and specificity (98.72%). C. albicans showed green colored colonies with 100% sensitivity and specificity respectively. C. kefyr showed pink color with sensitivity (61%) and specificity (92%). C. guilliermondi showed 95% sensitivity and 59% specificity. Hicrome agar differentiated mixed culture with all samples. Keywords: Hicrome agar-Candida, C. albicans, C. tropicalis. INTRODUCTION Oropharyngeal candidiasis continues to be a common opportunistic infection in patients infected with Human Immunodeficiency Virus (HIV) and it is the predictive of increasing immunosuppression. 1 Though Candida albicans is the predominant isolate, rise in frequency of isolation of non albicans Candida species is observed. Rapid and reliable identification of these Candida species is essential as they differ in their virulence and sensitivity to antifungal drugs. Routine identification of Candida species in the clinical microbiology laboratory is based upon the morphological characteristics such as the formation of pseudohyphae and terminal chlamydospores, clusters of blastoconidia at septa when grown on Corn meal agar at room temperature and the formation of germ tube in serum at 37 0 C. In addition, carbon source assimilation and fermentation tests or commercially available kits are also used as additional diagnostic tests. 2 Despite the
Content may be subject to copyright.
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 53
IJCRR
Vol 04 issue 23
Section: General Sciences
Category: Research
Received on: 01/10/12
Revised on: 27/10/12
Accepted on: 07/11/12
EVALUATION OF HICROME AGAR CANDIDA, A NEW
DIFFERENTIAL MEDIUM FOR ISOLATION OF CANDIDA SPECIES
FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Shyamala R., P. K. Parandekar, Aparna Y. Takpere
Department of Microbiology, BLDEU’s Sri B M Patil Medical College and Research
Centre, Bijapur, Karnataka, India
E-mail of Corresponding Author: drshyamalar@gmail.com
ABSTRACT
Background of study: Oral candidiasis is the most common opportunistic infection in HIV
seropositive patients, also predictive of immunosuppression. Though Candida albicans is the
predominant isolate in oral candidiasis, there is rise in non albicans Candida infection coupled with
high levels of antifungal resistance. There is urgent need for rapid, simple and reliable method to
identify yeast isolates. Hicrome agar- Candida is a selective and differential medium for identification
of yeasts directly from clinical samples. This medium allows selective isolation of yeasts and
simultaneously identifies certain species of Candida.
Aim / Objective: To evaluate the utility of Hicrome agar-Candida in identification of C. albicans and
non albicans Candida.
Research Methodology: Two oral swabs obtained from 100 HIV seropositive patients having oral
candidiasis were subjected to identification and characterization by standard conventional methods.
Simultaneously direct inoculation was done on Hicrome agar- Candida plate.
Conclusion: Of the total 100 samples 103 species were obtained. C. tropicalis was the most common
species isolated followed by C. guilliermondi, C. parapsilosis, C. kefyr, C. albicans, C. krusei, C.
glabrata, C. fomata and C. pelliculosa. Hicrome agar showed selective growth of all Candida species
with distinguishing color for each species. C. tropicalis showed blue color with sensitivity (68%) and
specificity (98.72%). C. albicans showed green colored colonies with 100% sensitivity and specificity
respectively. C. kefyr showed pink color with sensitivity (61%) and specificity (92%). C. guilliermondi
showed 95% sensitivity and 59% specificity. Hicrome agar differentiated mixed culture with all
samples.
Keywords: Hicrome agar-Candida, C. albicans, C. tropicalis.
INTRODUCTION
Oropharyngeal candidiasis continues to be a
common opportunistic infection in patients
infected with Human Immunodeficiency Virus
(HIV) and it is the predictive of increasing
immunosuppression.
1
Though Candida albicans is
the predominant isolate, rise in frequency of
isolation of non albicans Candida species is
observed. Rapid and reliable identification of these
Candida species is essential as they differ in their
virulence and sensitivity to antifungal drugs.
Routine identification of Candida species in the
clinical microbiology laboratory is based upon the
morphological characteristics such as the
formation of pseudohyphae and terminal
chlamydospores, clusters of blastoconidia at septa
when grown on Corn meal agar at room
temperature and the formation of germ tube in
serum at 37
0
C. In addition, carbon source
assimilation and fermentation tests or
commercially available kits are also used as
additional diagnostic tests.
2
Despite the
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 54
availability of these tests, the identification of
Candida species is laborious, time consuming and
sometimes difficult to interpret. These tests at
times may be inadequate or less sensitive and may
yield inaccurate identification especially when
atypical strains defying classical identification
characteristics are encountered.
Mixed growth having C. glabrata, C. krusei, C.
parapsilosis and other non albicans Candida are
associated with increasing frequency in these
patients. There is not only difficulty in their
identification, but also clinical therapeutic failure
to azoles as these organisms shows increased
resistance to azole group of drugs. This is due to
selective pressure or increased usage of
Fluconazole as prophylactic drug.
3, 4
Although
Automated systems are available to accurately
identify the isolates to species level and derive
their antifungal susceptibility pattern. These
automated systems proved to be considerably
expensive and are limited to few sophisticated
laboratories.
Several CHROMagar-Candida, a chromogen
based culture medium has been commercially
developed for rapid and reliable identification of
C. albicans, as these strains produce β-N-
acetylgalactosaminidase enzyme interacting on
chromophore substrate incorporated in the media
and gives green colored colonies.
3, 5
This media
also allows identification of mixed yeast isolates
from clinical samples, permitting presumptive
identification of C. albicans from other Candida
species.
Hicrome agar- Candida (Himedia, Mumbai, India)
is one such chromogenic medium employs the
same principle and helps in identifying Candida
isolates based on colony color and morphology.
Hicrome agar identifies C. albicans by imparting
green color to the colonies, C. tropicalis shows
blue color, C. glabrata showing green-purple
color, C. parapsilosis shows pink colored
colonies.
5, 6
Although the manufacturer claim that this media
shows better performance with good accuracy in
identifying Candida species, there is need to
establish its ability in selective isolation and
presumptive identification of Candida species,
before replacing conventional methods.
Thus the present study was carried out with the
objective to prove the utility of Hicrome agar in
identification of C. albicans and non albicans
Candida in quicker time as compared to
identification by conventional methods.
RESEARCH METHODOLOGY
The present study was carried out at the
Department of Microbiology, BLDEU’S Sri B M
Patil Medical college and Research centre,
Bijapur, Karnataka. The study was reviewed and
approved by the Institutional Ethical Committee.
Patients were included in the study if they were
HIV seropositive irrespective of duration of
infection of either sex and of all age group with
oral lesion characterized by cream- white, curdy
patches or erythematous lesions on dorsum of
tongue / buccal mucosa/ pharyngeal wall.
7
Those
patients who received antifungal treatment within
one month duration were excluded. After taking
written informed consent, specimens were
collected by firmly swabbing the lesion with two
sterile cotton swabs. One swab was used for
identification of yeasts by conventional methods
and the other swabbed directly on the Hicrome
agar plate. Hicrome agar was prepared according
to the manufacturer’s instructions.
Total 100 swabs showing positive for yeasts on
microscopy were subjected to culture on Emmon’s
modified Sabourauds Dextrose Agar (SDA)
supplemented with antibiotics (gentamicin 5µg
and chloramphenicol 50µg) and on Hicrome agar
plate, incubated at 37
0
C. Cream colored pasty
yeast colonies on SDA were subjected to Germ
Tube Test for two hours, morphology on Corn
meal agar (Dalmau Plate Culture method) read
after 48 hours and Auxonographic sugar
assimilation test incubated for 7 days for
identification of yeasts up to species level.
8
Hicrome agar plates were visualized daily at
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 55
24hrs, 72 hrs and followed up to 7 days to check
for colonial growth, characteristic color, color
intensification and for variation in colony
morphology .
6
Statistical analysis: Parameters like sensitivity
(true positive/true positive + false positive),
specificity (true negative/true negative+ false
positive) were determined.
RESULTS
The study group consists of 100 HIV seropositive
patients, comprised 71% male and 29% females.
Majority of the patients belong to age group
between 31-45 years(50%) followed by age
group16- 30 years(26%) and age group 46-60
years(20%). Mean age of the study group is 36
years. In our study, Non albicans Candida was the
most common species isolated accounting for
88.35% and Candida albicans accounting for
11.65%. Species distribution is given in table 1.
Out of 100 samples 103 Candida species were
obtained. All the isolates showed growth on
Hicrome within 24-36 hours, of size 1-3mm and it
was difficult to identify Candida species based on
color as the exact color and colony morphology
was not able to recognize easily within 24-36
hours. Increased Colony size and well
differentiated color and colony morphology were
well appreciated between 36-48 hours. But in
some rare species like C. pelliculosa , C. fomata
and one strain of C. tropicalis were observed with
well differentiated color after 72 hours, hence
there was statistical difference (P<0.01) between
time of growth and time for intensification of
color. Hicrome agar-Candida was able to
distinguish green, blue, pink and cream color
clearly after incubation up to 48hours. Sensitivity
and Specificity of each species is represented in
figure 1.
There was absolutely no batch- batch variation, as
tested by C. albicans ATCC 90028.
Three mixed cultures having six isolates were
identified based on colony color, size and texture.
All six isolates were obvious with their characters
and they could be easily identified (table 2).
While on SDA it needed lot of experience to
identify mixed growth, except for colony size,
there were no other defining variations with
different isolates.
There was no significant change in color after 72
hours on further incubation up to 7 days in almost
all strains.
DISCUSSION
In the present study, majority of the HIV patients
were in the age group of 31-45 years with mean
age 36 years with male preponderance accounting
for 71% which correlates well with other studies.
9,
10, 11, 12
Out of 103 Candida isolates obtained in our study,
species identification revealed that 91(88.35%)
were non albicans Candida, whereas remaining 12
(11.65%) were the C. albicans. In contrast to
studies of Lattiff et al.
13
and Enwuru CD et al.
14
who reported 86% and 40.5% of C. albicans
respectively. Challocombe SJ et al.
15
and Enwuru
CD et al.
14
reported 54% and 59.5% of Non
albicans Candida respectively, whereas our study
depicted non albicans Candida at much higher
prevalence revealing change in trend of infectious
agent replacing C. albicans. Perhaps, this may be
due to regional differences or selective pressure of
antifungal drug usage.
All 12 isolates of C. albicans showed green
colonies having sensitivity and specificity 100%
which correlated with Odd s et al.
16
Green colored
colonies, particularly distinctive for C. albicans
were easily identified.
C. tropicalis having sensitivity of 68% goes in
agreement with Hiroshi et al.
4
who reported 71%,
whereas Odds et al.
16
and Howarth et al.
17
had
sensitivity of more than 95%. This sensitivity in
our study is less as compared to others.
C. guilliermondi showed 95.72% sensitivity on
this medium which is comparable with Hospenthal
et al.
6
(96%). Only three isolates of C. parapsilosis
showed exact color as described having sensitivity
23.8%, Hospenthal et al.
6
also reported wide range
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 56
of colors for this species. Many of our isolates
showed cream colored colonies with defined
morphology instead of pink color which were not
included as true positives hence sensitivity of the
species reduced in our study. Hence it’s not only
the color but also the colonial morphology has to
be included for accurate interpretation.
C. kefyr and C. krusei had sensitivity of 61% and
44% respectively correlates with the study of
Pfaller et al.
18
who reported 66% each. We found
it difficult in identifying these species by their
colonial morphology as it was showing variation
in its appearance except for few which showed
typical morphology.
Even the secondary species like C. glabrata and C.
pelliculosa showed variation in their shades of
color and appearance as in study like Hovrth et
al.
17
This was the major limitations of the medium
where it was bit less accurate in identifying
uncommon species. This may be due to less
number of uncommon isolates obtained from our
study. This remarks us to carry out further
research on secondary species to prove their
distinctive character on Hicrome agar- Candida.
Recovery rate found on Hicrome agar was
equivalent on SDA in isolation of Candida species.
Hicrome agar Candida was slightly superior to the
Sabouraud agar in terms of its ability to suppress
bacterial contamination. Whereas, the CFU on
Hicrome agar were not only less as compared on
SDA but also the time taken to show exact growth
to be differentiated by color is prolonged with
mean duration 39 hours.
Our study found that colonial pigmentation and
typical morphology persisted throughout a seven-
day period as described by others and the
manufacturer of Hicrome agar. Hicrome agar-
Candida can readily be applied to identify colonies
after the 48 hours of incubation. The present study
highlights the fact that, Hicrome agar - Candida
differential medium proved to be very effective
for identification of four major Candida species
i.e. C. albicans, C. tropicalis, C. guilliermondi and
C. parapsilosis. As these isolates were readily
identified when isolated directly from oral thrush
patients in this study.
Its overall superiority has been self-evident in our
hands in its ability to reveal mixtures of yeast
species present in cultures. Hicrome agar not only
gave clue of mixed growth but also alerts to check
for mixed growth on SDA.
Routine use of chromogenic media carries the
potential for cost savings in the clinical
microbiology laboratory. Use of these media could
potentially save the time and expense of
performing assimilation tests and other
fermentative or biochemical testing. In addition,
use of CHROM agar Candida can also improve
the ability of the mycology laboratory to rapidly
identify mixed yeast infections. This capability
will also enable clinicians to more rapidly make
appropriate antifungal choices, decreasing patient
morbidity and mortality.
CONCLUSION
The Hicrome agar- Candida is adequately sensitive
to grow most of the important yeasts. C. albicans,
C. tropicalis, C. parapsilosis, C. krusei can be
identified rapidly and also ability to detect mixed
growth shows the usage of this media to higher
level. Hicrome agar-Candida can be readily used
for selective and differential isolation of Candida
species at quicker time.
ACKNOWLEDGEMENT
Authors acknowledge the immense help received
from the scholars whose articles are cited and
included in references of this manuscript. The
authors are also grateful to authors / editors /
publishers of all those articles, journals and books
from where the literature for this article has been
reviewed and discussed.
REFERENCES
1. Shobha D Nadiger, Sneha K Chunchanur, LH
Halesh, K Yasmeen, MR Chandrashekar and
Patil BS. Significance of isolation and drug
susceptibility testing of non- Candida albicans
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 57
species causing oropharyngeal candidiasis in
HIV patients. J Clin Microbiol 2008;
39(3):492-495.
2. Fotedar R and Al-Hedaithy S. S. A.
Identification of chlamydospore-negative
Candida albicans using CHROMagar Candida
medium. Mycoses 2003;46:96-103
3. Ainscough S and Kibbler CC. An evaluation
of the cost-effectiveness of using
CHROMagar for yeast identification in a
routine microbiology laboratory. J Med
Microbiol 1998; 47: 623-628.
4. Hiroshi Isogai, Mulu A, Diro E, H
Tekleselassie, Kassu A, Kimura K et al.
Identification of Candida species from Human
Immunodeficiency Virus-infected Patients in
Ethiopia by Combination of CHROMagar,
Tobacco agar and PCR of Amplified
Internally Transcribed rRNA Spacer
Region. J Applied Research 2010; 10 (1):2-8.
5. Baradkar V P, Mathur M, Kumar S. Hicrome
Candida agar for identification of Candida
species. Ind J Patho and Microbiol 2010;
53(1): 93-95.
6. Duane R Hospenthal, Miriam L Beckius,
Karon L Floyd, Lynn L Horvath and Clinton
K Murrar. Presumptive identification of
Candida species other than C. albicans, C.
krusei and C. tropicalis with the chromogenic
medium CHROMagar Candida. Ann of Clin
Microbiol and Antimicrobials 2006; 5:1-5.
7. Omar JM Hamza, Mecky IN Matee, Mainen J
Moshi, Elison NM Simon, Ferdinand Mugusi,
Frans HM Mikx et al. Species distribution and
invitro antifungal susceptibility of oral yeast
isolates from Tanzanian HIV-infected patients
with primary and recurrent oropharyngeal
candidiasis. BMC Microbiology 2008; 8:135.
8. Esther Segal and Daniel Eland. Topley and
Wilson’s Microbiology and Microbial
infection, Medical Mycology. In: William
GM, Roderick J Hay, editors. Candidiasis. 10
th
ed. Arnold publishers; p.577-578.
9. Vargas LOS and Lopez MGU. Oral isolates
colonizing of infecting Human
Immunodeficiency Virus infected and healthy
persons on Mexico. J Clin Microbiol 2005;
43(8):4159-62.
10. Anupriya A, Ravinder Kaur, Satish Kumar
Agarwal, Shyama Jain and Preena Bhalla.
AIDS related opportunistic mycoses seen in a
tertiary career hospital in North India. J Med
Microbiol 2007; 56:1101-6.
11. Mario Tumberllo, Germana Caldarola, Evelina
Tacconelli, Giulia Morace, Brunella P, Robert
Cauda et al. Analysis of the factors associated
with the emergence of azole resistant oral
candidiasis in the course of HIV infection. J
Antimicrobial Chemotherapy 1996; 38: 691-
699.
12. Ranganathan K, Narasimhan P and Vidya P.
Oral Candida species in Healthy and HIV
infected subjects in Chennai. Trop Med and
Health 2008; 3(2):101.
13. Lattif AA and Banerjee U. Susceptibility
pattern and molecular type of species, specific
Candida in oropharyngeal candidiasis of
Indian HIV positive patient. J Clin Microbiol
2004; 42(3):1260-2.
14. Enwuru CA, Ogunledin A, Idika N and
Ogbonna F. Fluconazole resistant
opportunistic oropharyngeal and non-Candida
yeast like isolates from HIV infected patient
attending to ART clinic in Lagos. African
Health Services 2008; 8(3):142-3.
15. Sweet SP, Challocombe SJ and Cookson S.
Candida albicans isolates from H IV-infected
and AlDS patients exhibit enhanced adherence
to epithelial cells. J Gen Microbiol 1995;
43:27-29.
16. Odds F C and R Bernaerts, CHROMagar
Candida, a new differential isolation medium
for presumptive identification of clinically
important Candida species. J Clin Microbiol
1994; 32(8):1923.
17. Lynn L. Horvath, Duane R. Hospenthal,
Clinton K Murray and David PD. Direct
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 58
Isolation of Candida spp. from Blood Cultures
on the Chromogenic Medium CHROMagar
Candida. J Clin Microbiol 2003; 41(6): 2629
2632.
18. Pfaller MA, Houstan A and Coffman S.
Application of CHROM agar Candida for
rapid screening of clinical specimens for
Candida albicans, Candida tropicalis, Candida
krusei and Candida glabrata. J Clin Microbiol
1996; 34(1):58-61.
Table I: Species distribution
Sl No
Species
Isolates (n)
Percentage
1
C. albicans
12
11.65%
2
C. tropicalis
25
24.27%
3
C. glabrata
21
20.39%
4
C. parapsilosis
13
12.62%
5
C. kefyr
13
12.62%
6
C.krusei
8
7.77%
7
C. glabrata
6
5.83%
8
C. fomata
3
2.91%
9
C. pelliculosa
1
0.97%
Total
103
100%
Table I: shows C. albicans 11.65%, among non
albicans Candida it is the Candida tropicalis
(24.27%) was frequently isolated species followed
by Candida guilliermondi (20.39%), Candida
parapsilosis (12.62%). Candida kefyr (12.62%),
Candida krusei (7.77%) were isolated. Rare
species like Candida glabrata (5.83%), Candida
fomata (2.91%) and Candida pelliculosa (0.97%)
were also isolated.
Table II: Mixed growth
SL
NO
SPECIES
On
SDA
On
Hicrome
COLOR
1
C.
guilliermondi
+
C. tropicalis
2
2
Green,
Pink
2
C. tropicalis +
C. parapsilosis
1
2
Blue,
Cream
3
C. fomata +
C. krusei
1
2
Cream,
Pink
Table II: shows three mixed cultures identified on
Hicrome agar plate with two species each and only
one mixed growth identified on SDA plate.
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 59
C. albicans
C.
tropicalis
C.
guilliermo
ndi
C.
parapsilos
is
C. kefyr
C. krusei
C.
glabrata
C.fomata
C.pelliculo
sa
Sensitivity
100
68
95.23
23.08
61.73
44.4
66.67
100
73.21
Specificity
100
98.72
59.75
86.66
92.22
70.21
86.5
100
86.49
0
20
40
60
80
100
120
PERCENTAGE
Figure 1: Sensitivity and Specificity of Candida
species on Hichrome agar
Figure 2: Candida albicans- Green colored colonies on Hicrome agar .
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 60
Figure 3: Candida tropicalis- Blue colored colonies on Hicrome agar
Figure 4: Candida parapsilosis- Pink colored colonies on Hicrome agar
Figure 5: Candida kefyr- Cream- Pink colonies on Hicrome agar
Shyamala R. et al
EVALUATION OF HICROME AGAR CANDIDA, A NEW DIFFERENTIAL MEDIUM FOR
ISOLATION OF CANDIDA SPECIES FROM ORAL TRUSH IN HIV SEROPOSITIVE PATIENTS
Int J Cur Res Rev, Dec 2012 / Vol 04 (23)
Page 61
Figure 6: Candida krusei- Pink colored colonies on Hicrome agar
Figure 7: Candida guilliermondi- Greenish purple colonies on Hicrome agar
Article
Full-text available
Candida kefyr (Kluyveromyces marxianus) is a clinically important infectious yeast. It is found in nature, and is known to cause diseases in humans. No previous studies known have shown the detection of Candida kefyr in water sources of any country, and no studies have detected it anywhere in Lebanon. This present study is carried out to assess the quality of Lebanese water in terms of yeast pollution. The occurrence of Candida spp. (species) was inspected in 84 water samples that tested positive for containing Candida. Out of all isolates, 12 isolates were of C. kefyr and two were of P. kluyveri. The identification of Candida sp. was carried out by using HiCrome™ M1297A and M1297AR chromogenic media. Isolates identified were confirmed by MALDI-TOF MS and 26S rRNA sequencing. The isolates varied from sensitive to resistant to common antifungal agents, including Itraconazole, clotrimazole, fluconazole, miconazole, and nystatin, via disk diffusion assay. These results are the first to confirm the presence of C. kefyr in Lebanese water supplies and suggest that water consumed in Lebanon may be a potential transmission route for serious Candida-based infections.
Article
Full-text available
The purpose of this study was to determine phenotypic and genotypic identification of Candida species from HIV infected patients in Ethiopia. Oral rinses from 13 human immunodeficiency virus (HIV) positive patients were inoculated on CHROMagar. Colonies were then sub cultured on To bacco agar. DNA was extracted from 71 colonies and amplified by PCR targeting the conserved regions of 18S, 5.8S, and 28S rRNAs. The amplified DNA samples were analyzed their sequence and a part of them were examined by restriction fragment length polymorphism (RFLP). Oral Candida colonization was detected in all of patients with or without oral candidiasis. The number of Candida species on the CHRO Magar was more than 1000 CFU/ml in 12 of 13 patients. We showed that phenotypic and genotypic identification process was important to determine the species. These results indicated that HIV-positive patients have high risk to C. albicans and the other Candida speceies infection in Ethipia.
Article
Full-text available
Oro-Pharyngeal Candidiasis (OPC) continues to be considered the most common opportunistic fungal disease in HIV/AIDS patients globally. Azole antifungal agent has become important in the treatment of mucosal candidiasis in HIV patients. Presently, antifungal drug resistance is fast becoming a major problem particularly with the immune depleted population. This study was designed to investigate the: existence of OPC, species distribution fluconazole susceptibility profile of yeast cells isolated from oral specimens of HIV/AIDS patients from Lagos Nigeria, between Oct. 2004 and June, 2005. The venous blood samples were screened for HIV antibodies using the Cappillus HIV I and II test kit (Trinity Biotech Plc UK), and Genie II HIV I and II EIA kit (Bio-Rad France). The positive results were subsequently confirmed at the laboratory attached to each of the clinics, using the Nigerian Federal Ministry of Health approved algorithm. The samples from 213 (108 females and 105 males) HIV positive patients were plated onto SD agar. The isolates were identified by morphotyping, microscopy and speciated using germ tube test and battery of biochemical sugar fermentation and assimilation tests. Fluconazole agar diffusion susceptibility testing was carried out on each isolates. Seventy-four (34.7%) isolates were recovered including one person with double isolates. Only 70 (94.6%) of the isolates could be adequately speciated. Candida albicans 30 (40.5%) was the most frequently isolated species, the rest were non-albicans species, with the frequency of C. tropicalis > C. Krusei > C. glabrata and C. neoformans for species for species having up to 4 isolates. Four (30.8%) out of 13 isolates of C. tropicalis showed germ tube formation. While one C. albicans was germ-tube negative. Out of the 74 isolates tested for fluconazole sensitivity, 58 (78.4%) were sensitive, MIC d'' 8 microg/ml, 9 (12.1%) were susceptible Dose Dependent (SDD), MIC 16-32 microg/ml and 7 (9.5%) were resistant, MICs e'' 64 microg/ml. Among the C. albicans isolates, 26 (86.7%) were sensitive to fluconazole. The rank of susceptibility was C. albicans > C. tropicalis > C. Krusei for the most prevalent species. We conclude that fluconazole resistant strains of oro-pharyngeal yeast-like cells exist in about 9.5% of HIV/AIDS patients with the above stated species distribution. We therefore, highlight the need for routine antifungal susceptibility testing on HIV patients with cases of initial or repeat episodes of OPC.
Article
Full-text available
In Tanzania, little is known on the species distribution and antifungal susceptibility profiles of yeast isolates from HIV-infected patients with primary and recurrent oropharyngeal candidiasis. A total of 296 clinical oral yeasts were isolated from 292 HIV-infected patients with oropharyngeal candidiasis at the Muhimbili National Hospital, Dar es Salaam, Tanzania. Identification of the yeasts was performed using standard phenotypic methods. Antifungal susceptibility to fluconazole, itraconazole, miconazole, clotrimazole, amphotericin B and nystatin was assessed using a broth microdilution format according to the guidelines of the Clinical and Laboratory Standard Institute (CLSI; M27-A2). Candida albicans was the most frequently isolated species from 250 (84.5%) patients followed by C. glabrata from 20 (6.8%) patients, and C. krusei from 10 (3.4%) patients. There was no observed significant difference in species distribution between patients with primary and recurrent oropharyngeal candidiasis, but isolates cultured from patients previously treated were significantly less susceptible to the azole compounds compared to those cultured from antifungal naïve patients. C. albicans was the most frequently isolated species from patients with oropharyngeal candidiasis. Oral yeast isolates from Tanzania had high level susceptibility to the antifungal agents tested. Recurrent oropharyngeal candidiasis and previous antifungal therapy significantly correlated with reduced susceptibility to azoles antifungal agents.
Article
Full-text available
The increased prevalence of oral candidosis associated with HIV infection must be intrinsically related to immunological changes in the host, but might also involve alterations to the infecting strains of yeast. This study aimed to determine if strains of Candida albicans isolated from asymptomatic HIV-infected individuals or AIDS patients possessed altered adherence properties in an in-vitro buccal epithelial cell (BEC) adherence assay. C. albicans isolates from 49 patients with HIV infection or AIDS adhered to BEC in significantly higher numbers than isolates from 49 control subjects (p < 0.001). No significant differences in adherence were detected between strains isolated from HIV-infected or AIDS subjects, or between strains isolated from C. Albicans carriers (low salivary C. albicans counts) or subjects with oral candidosis. The presence of whole saliva significantly inhibited the binding of candida to BEC (p < 0.001), but the significant difference in adherence between the HIV/AIDS and control isolates was maintained. The effect of saliva was independent of salivary candida antibodies and was abolished by treatment with protease or neuraminidase, suggesting the involvement of salivary mucins. The results of this study suggest that HIV infection is associated with the selection of strains of C. albicans with and increased ability to adhere to oral mucosa.
Article
Full-text available
The objective of this case-control study, conducted in a large Italian university hospital over a 12-month period, was to evaluate the risk factors associated with the emergence of azole resistant oral candidosis in 64 Human Immunodeficiency Virus (HIV) infected patients. A swab was obtained from each patient by brushing candidal lesions. Candida albicans was isolated in 41 patients (64%), Candida glabrata in ten (16%), Candida krusei in five (8%), Candida kefyr in two (3%), Candida tropicalis in two (3%), and Candida lipolytica and Candida guilliermondii in one case, respectively. Two patients suffered a double infection i.e. C. albicans+C. krusei and C. albicans+C. glabrata, respectively. Candida species were tested in vitro for their susceptibility to ketoconazole, fluconazole, itraconazole and amphotericin B. MICs of the four antifungal drugs were obtained for each yeast using a microdilution broth method developed in our laboratory. Twenty four (37%) of the isolated strains were resistant both to itraconazole and fluconazole, five (8%) to fluconazole alone, and two (3%) to ketoconazole alone, while none of the isolated strains was resistant to amphotericin B. Patients with oral candidosis caused by a strain resistant to one or more azole drug were compared to control patients with azole-susceptible oral candidosis. On univariate analysis, more than five episodes of oral candidosis in the last year (P = 0.01), previous use of azole therapy (P = 0.001), C2-3 category of HIV infection (P = 0.01) and low number of circulating CD4+ T-cells (P = 0.03) were significantly associated with an increased risk for the development of azole resistance. However, previous use of azole therapy was the only factor selected by a stepwise logistic regression analysis which was independently associated with the isolation of azole resistant strains (P = 0.003). Our findings indicate that, in view of the potential risk for the emergence and selection of azole resistant strains of Candida in patients with AIDS, it is important to carefully choose the antifungal drug for the therapy of mild fungal infections after evaluation of the in-vitro susceptibility of the isolated strains.
Article
Full-text available
CHROMagar Candida is a selective and differential chromogenic medium that has been shown to be useful for identification of Candida albicans, Candida krusei, Candida tropicalis, and perhaps Candida glabrata. Colony morphology and color have been well defined when CHROMagar Candida has been used to isolate yeast directly from clinical specimens, including stool, urine, respiratory, vaginal, oropharyngeal, and esophageal sources. Direct isolation of yeast on CHROMagar Candida from blood cultures has not been evaluated. We evaluated whether the color and colony characteristics produced by Candida spp. on CHROMagar Candida were altered when yeasts were isolated directly from blood cultures. Fifty clinical isolates of Candida were inoculated into aerobic and anaerobic blood culture bottles and incubated at 35 degrees C in an automated blood culture system. When growth was detected, an aliquot was removed and plated onto CHROMagar Candida. As a control, CHROMagar Candida plates were inoculated with the same isolate of yeast grown on Sabouraud dextrose agar simultaneously. No significant difference was detected in color or colony morphology between the blood and control isolates in any of the tested organisms. All C. albicans (n = 12), C. tropicalis (n = 12), C. glabrata (n = 9), and C. krusei (n = 5) isolates exhibited the expected species-specific colony characteristics and color, whether isolated directly from blood or from control cultures. CHROMagar Candida can be reliably used for direct isolation of yeast from blood cultures. Direct isolation could allow mycology laboratories to more rapidly identify Candida spp., enable clinicians to more quickly make antifungal agent selections, and potentially decrease patient morbidity and mortality.
Article
Objective: Candidiasis is the most common fungal infection in human immunodeficiency virus (HIV) - infected individuals. As there is sparse data on the oral Candida species in HIV- infected individuals in India, we characterized Candida species from the oral cavity in two cohorts - with and without HIV infection and with presence or absence of clinical oral candidiasis, in Chennai, South India. Methods: Saliva samples were collected from 147 consecutive study participants by the oral rinse technique. Candidal species were isolated by culturing specimens on Sabouraud‘s dextrose agar. The pure cultures so derived were speciated using the commercially available ID32C system, and the results were interpreted using APILAB plus software. Results: In the HIV seropositive group, the most commonly isolated candida species was C.albicans (86%) followed by C.tropicalis (23%), C.guilliermondi (6%), C.krusei (5%) and others (4%). In the healthy cohort without clinical candidiasis, C.tropicalis was the most commonly isolated species. Conclusion: There appears to be a marked variation in oral Candida species found in HIV-seropositive and seronegative individuals in India. To our knowledge, this is the first attempt to identify oral Candida species in a South Indian population.
Article
Chromogenic media are frequently used in direct and rapid identification of yeasts because different Candida species produce unique colors on these media. We used 60 isolates of Candida species including 30 C. albicans, 10 C. parapsilosis, 11 C. glabrata, five C. tropicalis, and four C. dubliniensis, isolated from various clinical specimens, to evaluate the performance of HiChrome Candida agar. These strains had been identified by germ tube test, morphology on cornmeal agar, chlamydospore formation on tobacco agar and sugar assimilation tests. The sensitivity and specificity results were: C. albicans (96.55 and 96.42%); C. parapsilosis (80 and 98.03%), C. glabrata (90.90 and 88.23%), C. tropicalis (100 and 100%) and C. dubliniensis (60 and 96.55%) respectively. HiChrom Candida agaris medium has been useful and capable of presumptive, rapid identification of Candida species within 48 hours.
Article
CHROMagar Candida is a novel, differential culture medium that is claimed to facilitate the isolation and presumptive identification of some clinically important yeast species. We evaluated the use of this medium with 726 yeast isolates, including 82 isolated directly on the medium from clinical material. After 2 days of incubation at 37 degrees C, 285 C. albicans isolates gave distinctive green colonies that were not seen with any of 441 other yeast isolates representing 21 different species. A total of 54 C. tropicalis isolates also developed distinctive dark blue-gray colonies with a halo of dark brownish purple in the surrounding agar. C. krusei isolates (n = 43) also formed highly characteristic rough, spreading colonies with pale pink centers and a white edge that was otherwise encountered only rarely with isolates of C. norvegensis. Trichosporon spp. (n = 34) formed small, pale colonies that became larger and characteristically rough with prolonged incubation. Most of the other 310 yeasts studied formed colonies with a color that ranged from white to pink to purple with a brownish tint. The only exceptions were found among isolates identified as Geotrichum sp. or Pichia sp., some of which formed colonies with a gray to blue color and which in two instances formed a green pigment or a dark halo in the agar. The specificity and sensitivity of the new medium for the presumptive identification of C. albicans, C. krusei, and C. tropicalis exceeded 99% for all three species. A blinded reading test involving four personnel and 57 yeast isolates representing nine clinically important species confirmed that colonial appearance after 48 h of incubation on CHROMagar Candida afforded the correct presumptive recognition of C. albicans, C. tropicalis, C, krusei, and Trichosporon spp. None of nine bacterial isolates grew on CHROMagar Candida within 72 h, and bacteria (Escherichia coli) grew from only 4 of 104 vaginal, 100 oral, and 99 anorectal swabs. The new medium supported the growth of 19 of 23 dermatophyte fungi tested and 41 of 43 other molds representing a broad range of fungal pathogens and contaminants. In parallel cultures of 348 clinical specimens set up on Sabourand agar and CHROMagar Candida, both media grew yeasts in the same 78 instances. CHROMagar Candida is recommended as a useful isolation medium capable of the presumptive identification of the yeast species most commonly isolated from clinical material and facilitating recognition of mixed yeast cultures.
Article
CHROMagar, a chromogenic differential culture medium, is claimed to facilitate the isolation and presumptive identification of certain clinically important yeast species, e.g., Candida albicans. This study evaluated the cost-effectiveness and time advantage of using it in comparison with Sabouraud dextrose agar (SDA). Three possible pathways, each of which included the use of one or both media, were compared in a routine laboratory. A total of 21 yeast isolates was cultured from 298 clinical samples from neutropenic and AIDS patients. An overall sensitivity of 95.2% was observed for each medium and primary isolation on CHROMagar was found to be 100% sensitive and 100% specific for C. albicans. For identification purposes, after initial culture the use of CHROMagar provided the most economical and least time-consuming method. Direct inoculation on to CHROMagar is recommended for blood cultures when yeast cells are seen on microscopy and where early appropriate therapy is imperative.